TGen, the Translational Genomics Research Institute, is an affiliate of City of Hope. We are an Arizona-based, nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results. We work to unravel the genetic components of common and complex diseases, including cancer, neurological disorders, infectious disease, and rare childhood disorders. By identifying treatment options in this manner, we believe medicine becomes more rational, more precise and, well, more personal.
We use 'precision medicine' to apply the right dose of the right treatment to the right patient at the right time.
Watch Video
From ALS and Alzheimer's to stroke and concussion, scientists search for early warning signs and effective treatments.
To address the greatest public health threats, we track outbreaks, create better diagnostics and smarter treatments.
We conduct genomic sequencing to end the diagnostic odyssey for rare disease patients and their families.
Press Release for March 18, 2019 - Licensing agreement puts DeepChek®-TB...
Read more
Tuberous Sclerosis Complex is a genetic disorder characterized by the growt...
TGen is looking for individuals who currently play or have previously playe...
A child diagnosed today with DIPG faces the same prognosis as a child diagn...
Participate in our collaborative effort to help us learn more about brain-r...
You are one click away from the Multiple System Atrophy (MSA) Research Regi...
The purpose of this study is to identify the molecular basis of SCCO.
Dr. Kendall Van Keuren-Jensen, a Professor in TGen Neurogenomics Divis...
More Talks
The Dorrance Challenge provides a dollar-for-dollar match that doubles the ...
More
